Substance Abuse and Mental Health Services Administration (SAMHSA)

Substance Abuse and Mental Health Services Administration
(SAMHSA)

Center for
Substance Abuse Treatment (CSAT)
Telephone (240) 276-2717

1Choke
Cherry Road, Room 2-1065
Facsimile (240) 276-1630

Rockville,
Maryland 20857
E-mail: [email protected]

Division
of Pharmacologic Therapies
DPT

C. Todd Rosendale, MA

Public Health Advisor

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ FACSIMILE

AInformation Memorandum@

 

This facsimile is intended only for the
addressee indicated below, and any review, dissemination or
use of this trans-
Mission or its contents by
persons other than the addressee
is
strictly prohibited in accordance with 42 CFR Part 2,
Confidentiality
of Alcohol and Drug Abuse Patient Records

TO: State Methadone Authorities

Opioid Treatment
Programs:

Alabama, Arkansas,
Florida,

Georgia,
Kentucky, Louisiana,

Missouri, N. Carolina, S. Carolina,

Oklahoma, Tennessee, Texas

 

FROM:C. Todd Rosendale, MA

 

RE: Emergency
Medication for Patients of Programs

Impacted
by Hurricane Katrina

 

DATE: August 31, 2005

 

 

 

The Division of Pharmacologic
Therapies is aware of the growing need to provide access to medication for the
large number of patients displaced from the programs impacted either directly
or indirectly by Hurricane Katrina, and we have the following guidance relative
to the provision of emergency medication to those persons identifying
themselves as patients of one of the affected treatment programs. Many of the patients you encounter will not
only need medication, they will also have suffered the loss of their residence
and have no assurance as to when and where they will relocate. Therefore, please include a large dose of
compassion with your usual due caution when dispensing methadone.

 

Emergency Guidance:

 

~ All necessary identification and
dosing information relative to patients of the DRD New Orleans Medical Clinic
can be ascertained by calling (800) 447-8801 and asking for Janet or Laura.

 

~ If you are unable to contact the
patients home program, the following procedures should be combined with your
existing emergency plans:

 

1)     
The emergency guest patient should show valid
picture identification which includes an address in close proximity to the
areas impacted by Hurricane Katrina.

2)     
The patient should show some type of proof that
indicates they were receiving services from a clinic located in one of the
devastated areas (medication bottle, program identification card, receipt for
payment of fees, etc.). In cases where
the patient does not have any items of proof, the program may use their best
clinical/medical judgment, possibly combined with a stat drug test for the
presence of methadone (dip stick, etc.).

3)     
The program may administer the amount of medication
that the patient reports as their current dose; however, remind each patient
that the dose they report will be verified with the home program ASAP. In cases where the reported dose appears
questionable, it is best to use good medical judgment when determining the dose
level.

4)     
Emergency guest patients should be medicated daily
with take-home doses provided only for days that the program is closed (Sundays
and holidays). In the case of a patient
who must travel an extreme distance to receive the medication, take-home
medication may be considered via the SMA-168 Request for Exception process.

5)     
The submission of an SMA-168 Request for Exception
to CSAT will not be necessary for the emergency guest patient; however, the
following information should be collected daily and submitted to CSAT when all
patients have returned to their home programs or have been permanently
relocated to another program:

a)                 
assign each patient a guest clinic identification
number and compile a temporary chart.

b)                 
attempt to contact the home program of the emergency
guest patient each day prior to administering the medication and record the
result in the temporary chart.

c)                 
record the day, date and amount of medication
administered to each patient along with any observations made by the staff
person.

 

Should there be any questions or
issues not covered in this Information
Memorandum
, please feel free to call me at (240) 276-2717.

 

The Medication Assisted Treatment community
of OTPs should be very proud. Their immediate
offers of assistance and outpouring of concern to the patients whose lives have
been impacted so drastically has been gratifying.

 

We have attached contact information
for 37 OTPs in three states to aid in contacting the home programs for displaced
patients.

 

 

 

 

Similar Posts

  • Office Based Opioid Treatment (OBOT)

    Admin 12/18/2022

    What Is Office Based Opioid Treatment or OBOT? OBOT is the treatment of opiate addiction with a medication in a physicians’ office and outside of the clinic system. Two medications are available methadone and buprenorphrine that was recently approved. Each medication has specific requirements and regulations before it can be dispensed. Using buprenorphine the physician…

  • Blind Dosing

    Admin 05/05/2023

    Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…

  • Category: Lane Holden Award

    Admin 07/18/2022

    Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! May 1, 2022 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive Director of Man Alive and later served as Vice President…

  • About Webring

    Admin 06/30/2021

    Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager: Greg Keller,…

  • State Ceases Tests to Spot Methadone Misuse

    Admin 06/16/2023

    The Associated Press State & Local Wire, May 3, 2005. DATELINE: Baltimore The state health department has stopped running laboratory tests for Maryland’s methadone clinics, removing a safeguard against misuse of the drug, potentially worsening what authorities say is a growing problem. Methadone, a heroin replacement medication, is used by about 13,400 recovering addicts in…

  • Stigma: The Invisible Barrier by Herman Joseph and Joycelyn Woods

    Admin 12/13/2021

    Herman Joseph, Ph.D. is a member of NAMA’s Advisory Board and has been involved in methadone treatment and research since it’s beginning. This article is excerpted from Herman Joseph’s dissertation on stigma. Methadone maintenance treatment has been subjected to professional trivialization and misunderstandings, has consistently received sensationalized negative media coverage and been the target of…